Research Site
Raipur 492001
1 studies enrolling now · 2 studies all time
What they study most
Breast Cancer, Breast Neoplasms, HER2-positive Early Breast Cancer, Metastatic Non-small Cell Lung Cancer
Studies at this site
- A Study to Investigate the Efficacy and Safety of Dato-DXd With or Without Osimertinib Compared With Platinum Based Doublet Chemotherapy in Participants With EGFR-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer — Recruiting now
- Trastuzumab Deruxtecan (T-DXd) Alone or in Sequence With THP, Versus Standard Treatment (ddAC-THP), in HER2-positive Early Breast Cancer — Running, not enrolling